Safe, effective one-year outcomes in severe tricuspid regurgitation, enhancing symptoms and reducing admissions.

Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed. In this international, multicenter trial, we randomly assigned 400 patients with severe symptomatic ...

PASCAL repair offers lasting TR reduction, better survival, and improved quality of life in severe tricuspid regurgitation.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...